Inventor · disambiguated record
William J. Geese
Also filed as: GEESE WILLIAM J
6 granted patents·7 pending applications·10 citations·filing 2006–2025
75Inventor score
Files withBRISTOL MYERS SQUIBB CO13
Top patents by PatentIndex Score
13 records- 0190US11919957B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 5, 2024·4 cites·13 claims
- 0287US12466888B2Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Nov 11, 2025·1 cites·19 claims
- 0386US12227576B2Methods of treating a tumor using an anti-PD-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Feb 18, 2025·1 cites·20 claims
- 0480US11566073B2Methods of treating a tumor using an anti-PD-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 31, 2023·4 cites·20 claims
- 0573US2025059610A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0667US2023295737A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0765US2024190963A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0862US7598029B2Method for identifying HIV-1 protease inhibitors with reduced metabolic affectsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Oct 6, 2009·0 cites·8 claims
- 0961US2025145713A1Methods of treating a tumor using an anti-pd-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1059US2020239577A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1151US2021101980A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1244US2021032344A1Methods of treating tumorBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1342US7482124B2Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edemaBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when William J. Geese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →